UA92077C2 - Таблетка, що диспергується у роті - Google Patents

Таблетка, що диспергується у роті

Info

Publication number
UA92077C2
UA92077C2 UAA200812192A UAA200812192A UA92077C2 UA 92077 C2 UA92077 C2 UA 92077C2 UA A200812192 A UAA200812192 A UA A200812192A UA A200812192 A UAA200812192 A UA A200812192A UA 92077 C2 UA92077 C2 UA 92077C2
Authority
UA
Ukraine
Prior art keywords
orodispersible
domperidone tablets
orodispersible domperidone
tablets
nucrocrystalline
Prior art date
Application number
UAA200812192A
Other languages
English (en)
Russian (ru)
Inventor
Жан-Франсуа Кордольяні
Дідьє Бертумьйо
Original Assignee
Пьєр Фабр Медікамент
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пьєр Фабр Медікамент filed Critical Пьєр Фабр Медікамент
Publication of UA92077C2 publication Critical patent/UA92077C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Винахід стосується таблетки, що диспергується у роті, яка містить за вагою: максимально 15 % низькодозової терапевтично активної речовини; від 55 % до 70 % маніту з розміром частинок від 30 мкм до 300 мкм; щонайменше 2 % мальтодекстрину; від 3,5 % до 8 % натрійкроскармелози; від 10 % до 20 % мікрокристалічної целюлози; від 0,5 % до 1,5 % стеарату магнію; і від 1 % до 5 % коригенту (коригентів) і підсолоджуючої речовини (підсолоджуючих речовин).
UAA200812192A 2006-03-15 2007-03-14 Таблетка, що диспергується у роті UA92077C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0602253A FR2898492B1 (fr) 2006-03-15 2006-03-15 Comprimes orodispersibles de domperidone
PCT/EP2007/052388 WO2007104771A1 (en) 2006-03-15 2007-03-14 Orodispersible domperidone tablets

Publications (1)

Publication Number Publication Date
UA92077C2 true UA92077C2 (uk) 2010-09-27

Family

ID=37580660

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200812192A UA92077C2 (uk) 2006-03-15 2007-03-14 Таблетка, що диспергується у роті

Country Status (30)

Country Link
US (1) US8852633B2 (uk)
EP (1) EP2007384B1 (uk)
JP (1) JP5184383B2 (uk)
KR (1) KR101468750B1 (uk)
CN (1) CN101394850B (uk)
AR (1) AR059852A1 (uk)
AT (1) ATE435016T1 (uk)
AU (1) AU2007224419B2 (uk)
BR (1) BRPI0708880A2 (uk)
CA (1) CA2645629C (uk)
CY (1) CY1109405T1 (uk)
DE (1) DE602007001465D1 (uk)
DK (1) DK2007384T3 (uk)
ES (1) ES2328532T3 (uk)
FR (1) FR2898492B1 (uk)
HK (1) HK1125848A1 (uk)
IL (1) IL193878A (uk)
MA (1) MA30378B1 (uk)
MX (1) MX2008011835A (uk)
NO (1) NO20084276L (uk)
NZ (1) NZ571772A (uk)
PL (1) PL2007384T3 (uk)
PT (1) PT2007384E (uk)
RU (1) RU2449793C2 (uk)
SI (1) SI2007384T1 (uk)
TN (1) TNSN08349A1 (uk)
TW (1) TWI389708B (uk)
UA (1) UA92077C2 (uk)
WO (1) WO2007104771A1 (uk)
ZA (1) ZA200808274B (uk)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2018153B1 (en) * 2006-04-26 2012-04-11 Rosemont Pharmaceuticals Ltd Liquid oral compositions
FR2909877B1 (fr) * 2006-12-13 2009-07-10 Galenix Dev Soc Par Actions Si Composition pharmaceutique contenat de la 5-chloro-1-[1-[3- (2-oxo-2,3-dihydro-1h-benzimidazol-1-yl)propyl] piperidin-4-yl]-1,3-dihydro-2h-benzimidazol-2-one et son procede de preparation
JP2009114113A (ja) * 2007-11-06 2009-05-28 Nipro Corp 口腔内崩壊錠及びその製造方法
JP2010241760A (ja) * 2009-04-09 2010-10-28 Takada Seiyaku Kk 不快な味の軽減された口腔内速崩壊錠及びその製造方法
ES2422281T3 (es) 2009-04-09 2013-09-10 E Pharma Trento Spa Granulado para la formulación de comprimidos bucodispersables
KR20130009553A (ko) * 2011-07-15 2013-01-23 한미약품 주식회사 몬테루카스트 또는 이의 약학적으로 허용가능한 염 및 레보세티리진 또는 이의 약학적으로 허용가능한 염을 함유하는 캡슐 제제
CN104127390B (zh) * 2014-08-05 2016-05-11 孙丽华 一种多潘立酮片及其制备工艺
CN106236727B (zh) * 2016-08-30 2018-11-09 林州中农颖泰生物肽有限公司 一种安乃近泡腾片及其制备方法
MX2023003432A (es) * 2020-09-29 2023-08-04 Millicent Pharma Ltd Formulaciones orodispersables.
CN112656690A (zh) * 2021-01-29 2021-04-16 南京科技职业学院 一种适用于固体原料分散制粒的制药工艺方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
KR100481583B1 (ko) * 1996-06-14 2005-07-12 교와 핫꼬 고교 가부시끼가이샤 구강내에서빠르게붕괴하는정제
US8071128B2 (en) * 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
AU733032C (en) * 1996-06-14 2002-01-03 Kyowa Hakko Kirin Co., Ltd. Intraorally rapidly disintegrable tablet
NZ505123A (en) * 1997-12-19 2003-07-25 Smithkline Beecham Corp Process for manufacturing bite-dispersion tablets by compressing medicaments and other ingredients into granulates then compressing the granulates and other ingredients into tablets, and the tablets thereof
KR20010006835A (ko) 1999-03-25 2001-01-26 김선진 경구용 속붕해정
AU3574500A (en) 1999-03-25 2000-10-16 Yuhan Corporation Rapidly disintegrable tablet for oral administration
PT1200090E (pt) * 1999-08-03 2013-11-25 Icos Corp Formulação farmacêutica à base de um beta-carbolina e seu uso para tratar a disfunção sexual.
AR030630A1 (es) * 2000-09-11 2003-08-27 Novartis Ag Composiciones farmaceuticas
US7118765B2 (en) * 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
FR2858556B1 (fr) * 2003-08-06 2006-03-10 Galenix Innovations Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation

Also Published As

Publication number Publication date
TWI389708B (zh) 2013-03-21
AU2007224419B2 (en) 2012-12-20
CN101394850B (zh) 2013-05-29
NZ571772A (en) 2010-06-25
JP2009530244A (ja) 2009-08-27
EP2007384B1 (en) 2009-07-01
PT2007384E (pt) 2009-08-25
ES2328532T3 (es) 2009-11-13
PL2007384T3 (pl) 2009-12-31
MA30378B1 (fr) 2009-05-04
IL193878A (en) 2011-02-28
WO2007104771A1 (en) 2007-09-20
US20090081288A1 (en) 2009-03-26
TW200812644A (en) 2008-03-16
ATE435016T1 (de) 2009-07-15
RU2449793C2 (ru) 2012-05-10
KR101468750B1 (ko) 2014-12-03
RU2008139969A (ru) 2010-04-20
AU2007224419A1 (en) 2007-09-20
BRPI0708880A2 (pt) 2011-06-14
MX2008011835A (es) 2008-09-29
ZA200808274B (en) 2009-08-26
CY1109405T1 (el) 2014-07-02
AR059852A1 (es) 2008-04-30
NO20084276L (no) 2008-11-26
DE602007001465D1 (de) 2009-08-13
FR2898492A1 (fr) 2007-09-21
HK1125848A1 (en) 2009-08-21
TNSN08349A1 (en) 2009-12-29
CN101394850A (zh) 2009-03-25
CA2645629C (en) 2014-04-29
KR20080111473A (ko) 2008-12-23
CA2645629A1 (en) 2007-09-20
FR2898492B1 (fr) 2008-06-06
US8852633B2 (en) 2014-10-07
JP5184383B2 (ja) 2013-04-17
EP2007384A1 (en) 2008-12-31
DK2007384T3 (da) 2009-09-07
SI2007384T1 (sl) 2009-12-31

Similar Documents

Publication Publication Date Title
UA92077C2 (uk) Таблетка, що диспергується у роті
WO2009043844A3 (en) Orodispersible tablets
CA2487834A1 (en) Orally disintegrating tablets and process for obtaining them
MX343358B (es) Tabletas de acetato de ulipristal.
FI2508188T3 (fi) Dapagliflotsiinipropyleeniglykolihydraattia sisältäviä farmaseuttisia formulaatioita
WO2011060290A8 (en) Immediate release tablet formulations
WO2009006095A3 (en) Dual portion lozenge dosage form
MY139086A (en) Use of debranched starch in extrusion-spheronization pharmaceutical pellets
MX2008012731A (es) Tabletas de paracetamol de liberacion rapida.
MX2010005175A (es) Comprimido dispersable oral.
NO20082265L (no) Dispergerbare tabletter som innbefatter deferasirox
MXPA05002942A (es) Forma de dosificacion oral de liberacion modificada.
JP5259880B2 (ja) 経口剤
UY30365A1 (es) Comprimido bicapa para la prevención de los accidentes cardiovasculares
UA116334C2 (uk) Тверді форми дозування бендамустину
EA201001108A1 (ru) Диспергируемые во рту таблетки, содержащие основание эсциталопрама, и способ их получения
TW200700062A (en) Pharmaceutical compositions
WO2007134158A3 (en) Granules comprising calcium carbonate, a binder and a porosity increasing agent, processes of manufacturing, use in therapy
WO2005007137A3 (de) Ambroxolhaltige tabletten
WO2003086362A3 (en) Method of stabilizing bupropion hydrochloride tablets
MXPA06000332A (es) Nueva composicion farmaceutica solida que comprende amisulprida.
UA95274C2 (uk) Твердий фармацевтичний препарат, що містить ірбесартан, та способи його виготовлення
ZA200506992B (en) Fibrate tablet and method for the production thereof
WO2009135950A3 (en) Process for preparing a tablet containing excipients
HK1075390A1 (en) Citalopram for the treatment of elevated blood pressure